Exploring the mechanism of Cassiae semen in regulating lipid metabolism through network pharmacology and experimental validation

Abstract Background: Multiple studies have assessed the role of Cassiae semen (CS) in regulating lipid metabolism. However, the mechanism of action of CS on non-alcoholic fatty liver disease (NAFLD) has seen rare scrutiny. Objective: The objective of this study was to explore the regulatory mechanism of CS on lipid metabolism in NAFLD. Methods: Components of CS ethanol extract (CSEE) were analyzed and identified using UPLC-Q-Orbirap HRMS. The candidate compounds of CS and its relative targets were extracted from the Traditional Chinese Medicine Systems Pharmacology, Swiss-Target-Prediction, and TargetNet web server. The Therapeutic Target Database, Genecards, Online Mendelian Inheritance in Man, and DisGeNET were searched for NAFLD targets. Binding affinity between potential core components and key targets was established employing molecular docking simulations. After that, free fatty acid (FFA)-induced HepG2 cells were used to further validate part of the network pharmacology results. Results: Six genes, including Caspase 3 (CASP3), phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit α (PIK3CA), epidermal growth factor receptor (EGFR), and amyloid β (A4) precursor protein (APP) were identified as key targets. The mitogen-activated protein kinase (MAPK) signaling pathway was found to associate closely with CS’s effect on NAFLD. Per molecular docking findings, toralactone and quinizarin formed the most stable combinations with hub genes. About 0.1 (vs. FFA, P<0.01) and 0.2 (vs. FFA, P<0.05) mg/ml CSEE decreased lipid accumulation in vitro by reversing the up-regulation of CASP3, EGFR, and APP and the down-regulation of PIK3CA. Conclusion: CSEE can significantly reduce intracellular lipid accumulation by modulating the MAPK signaling pathway to decrease CASP3 and EGFR expression.

[1]  Shuiming Xiao,et al.  Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota , 2021, Communications Biology.

[2]  J. Sohng,et al.  Quinizarin suppresses the differentiation of adipocytes and lipogenesis in vitro and in vivo via downregulation of C/EBP-beta/SREBP pathway. , 2021, Life sciences.

[3]  H. Guillou,et al.  New targets for NAFLD , 2021, JHEP reports : innovation in hepatology.

[4]  Z. Dai,et al.  SIMPLE Is an Endosomal Regulator That Protects Against NAFLD by Targeting the Lysosomal Degradation of EGFR , 2021, Hepatology.

[5]  Gun-Hee Kim,et al.  Lactiplantibacillus plantarum MG4296 and Lacticaseibacillus paracasei MG5012 Ameliorates Insulin Resistance in Palmitic Acid-Induced HepG2 Cells and High Fat Diet-Induced Mice , 2021, Microorganisms.

[6]  Xiongbiao Wang,et al.  Investigation of the Active Ingredients and Mechanism of Polygonum cuspidatum in Asthma Based on Network Pharmacology and Experimental Verification , 2021, Drug design, development and therapy.

[7]  P. Fariselli,et al.  Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? , 2021, Gut.

[8]  Shi Feng,et al.  Danggui Buxue Decoction in the Treatment of Metastatic Colon Cancer: Network Pharmacology Analysis and Experimental Validation , 2021, Drug design, development and therapy.

[9]  Peter B. McGarvey,et al.  UniProt: the universal protein knowledgebase in 2021 , 2020, Nucleic Acids Res..

[10]  Chengfu Xu,et al.  Functions of amyloid precursor protein in metabolic diseases. , 2020, Metabolism: clinical and experimental.

[11]  W. Chatuphonprasert,et al.  Cytochrome P450 expression-associated multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) in HepG2 cells , 2020 .

[12]  M. Um,et al.  Cassia tora Seed Improves Pancreatic Mitochondrial Function Leading to Recovery of Glucose Metabolism. , 2020, The American journal of Chinese medicine.

[13]  Hongliang Li,et al.  Epidemiological Features of NAFLD From 1999 to 2018 in China , 2020, Hepatology.

[14]  Feng Zhu,et al.  Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics , 2019, Nucleic Acids Res..

[15]  Jun Li,et al.  TMEM100 mediates inflammatory cytokines secretion in hepatic stellate cells and its mechanism research. , 2019, Toxicology letters.

[16]  Jong-Choon Kim,et al.  Subchronic toxicity evaluation of ethanol extract of Cassia tora L. seeds in rats. , 2019, Regulatory toxicology and pharmacology : RTP.

[17]  G. Michalopoulos,et al.  Pharmacologic Inhibition of Epidermal Growth Factor Receptor Suppresses Nonalcoholic Fatty Liver Disease in a Murine Fast‐Food Diet Model , 2019, Hepatology.

[18]  Yu Cao,et al.  Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma , 2019, Molecular oncology.

[19]  Xingtong Shen,et al.  Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease , 2019, Journal of cellular physiology.

[20]  Olivier Michielin,et al.  SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules , 2019, Nucleic Acids Res..

[21]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[22]  J. Chan,et al.  Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non‐alcoholic fatty liver disease , 2018, Alimentary pharmacology & therapeutics.

[23]  L. Henry,et al.  NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .

[24]  M. Yoneda,et al.  Current and future pharmacological therapies for NAFLD/NASH , 2017, Journal of Gastroenterology.

[25]  Yuan Wu,et al.  P38 MAPK pathway mediates cognitive damage in pentylenetetrazole-induced epilepsy via apoptosis cascade , 2017, Epilepsy Research.

[26]  Y. Jang,et al.  Toralactone glycoside in Cassia obtusifolia mediates hepatoprotection via an Nrf2-dependent anti-oxidative mechanism. , 2017, Food research international.

[27]  Xiaoxv Dong,et al.  Cassiae semen: A review of its phytochemistry and pharmacology , 2017, Molecular medicine reports.

[28]  Núria Queralt-Rosinach,et al.  DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..

[29]  R. Casadio,et al.  Large scale analysis of protein stability in OMIM disease related human protein variants , 2016, BMC Genomics.

[30]  R. Casadio,et al.  Large scale analysis of protein stability in OMIM disease related human protein variants , 2016, BMC Genomics.

[31]  Jie Dong,et al.  TargetNet: a web service for predicting potential drug–target interaction profiling via multi-target SAR models , 2016, Journal of Computer-Aided Molecular Design.

[32]  B. Staels,et al.  Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease. , 2016, Annual review of physiology.

[33]  T. Aittokallio,et al.  Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products. , 2015, Natural product reports.

[34]  A. Wree,et al.  Caspase 3 Inactivation Protects Against Hepatic Cell Death and Ameliorates Fibrogenesis in a Diet-Induced NASH Model , 2014, Digestive Diseases and Sciences.

[35]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[36]  L. Qian.  Analysis of the volatile constituents of Semen Cassiae by HS-SPME combined with GC-MS , 2014 .

[37]  C. Trautwein,et al.  Hepatocyte caspase‐8 is an essential modulator of steatohepatitis in rodents , 2013, Hepatology.

[38]  Shao Li,et al.  Traditional Chinese medicine network pharmacology: theory, methodology and application. , 2013, Chinese journal of natural medicines.

[39]  Hung-Jen Lu,et al.  Reduction of lipid accumulation in white adipose tissues by Cassia tora (Leguminosae) seed extract is associated with AMPK activation. , 2013, Food chemistry.

[40]  M. Ávila,et al.  The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis , 2013, Journal of Gastroenterology.

[41]  D. Torres,et al.  Features, diagnosis, and treatment of nonalcoholic fatty liver disease. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[42]  Hua Yu,et al.  A Novel Chemometric Method for the Prediction of Human Oral Bioavailability , 2012, International journal of molecular sciences.

[43]  Y. Takikawa,et al.  Carnosic acid (CA) prevents lipid accumulation in hepatocytes through the EGFR/MAPK pathway , 2012, Journal of Gastroenterology.

[44]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[45]  Roger L. Williams,et al.  Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases , 2011, Oncogene.

[46]  Ling Lin,et al.  Lipotoxicity in HepG2 cells triggered by free fatty acids. , 2011, American journal of translational research.

[47]  Tsviya Olender,et al.  GeneCards Version 3: the human gene integrator , 2010, Database J. Biol. Databases Curation.

[48]  Pornpimol Charoentong,et al.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..

[49]  L. Yong.  ANALYSIS ON CHEMICAL COMPONENT PRINCIPLES OF CASSIA OBTUSIFOLIA BY HPLC-ESI-MS , 2008 .

[50]  V. Dixit,et al.  Hypolipidemic activity of seeds of Cassia tora Linn. , 2004, Journal of ethnopharmacology.

[51]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.